Comparison of triazolam and pentobarbital: performance impairment, subjective effects and abuse liability.
The DOI matches its Crossref record.
Abstract
On a residential research ward, the acute effects of placebo, 0.5 to 3.0 mg of triazolam (TZ) and 100 to 600 mg of pentobarbital (PTB) were examined using a within-subject, double-blind design in male volunteers with documented histories of drug abuse. Drug effects were examined through the use of subject ratings including measures of drug liking and estimates of street value, staff ratings, objective psychomotor/cognitive performance measures, subject estimates of performance, immediate and delayed recognition memory tasks and subject ratings of nighttime sleep quality. Staff ratings and objective performance measures showed that TZ and PTB produced comparable dose-related impairment; TZ had a more rapid onset and a shorter duration of action than PTB. With these measures, TZ was 159 to 274 times more potent than PTB. With subject-rated measures of drug effect, sleepiness and drunkenness, in contrast, TZ produced smaller effects than PTB or was only 135 to 163 times more potent than PTB. Similarly, with subject ratings of drug liking and estimated street value, TZ produced smaller effects than PTB and was only 91 to 122 times more potent than PTB. Other results showed that TZ produced greater amnestic effects than PTB and subjects under the influence of TZ more consistently underestimated the degree of their impairment. Overall, these results suggest that TZ has a lower liability for abuse (likelihood) than PTB, but a greater liability of abuse (hazard) with regard to performance impairment on certain kinds of tasks.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Griffiths, R. R., & Weerts, E. M. (1997) · Psychopharmacology · doi:10.1007/s002130050422 · Cited by 260
Self-citationA review of the neuropsychological effects of commonly used prescription medications
Stein, R. A., & Strickland, T. L. (1998) · Archives of Clinical Neuropsychology · doi:10.1093/arclin/13.3.259 · Cited by 98
Alprazolam absorption kinetics affects abuse liability
Mumford, G. K., Evans, S. M., Fleishaker, J. C., & Griffiths, R. R. (1995) · Clinical Pharmacology & Therapeutics · doi:10.1016/0009-9236(95)90162-0 · Cited by 63
Riba, J., Rodríguez-Fornells, A., Urbano, G., Morte, A., Antonijoan, R., & Barbanoj, M. (2001) · Psychopharmacology · doi:10.1007/s002130100816 · Cited by 60
Metadata
- Authors
- Roache, J. D., & Griffiths, R. R.
- Venue
- The Journal of Pharmacology and Experimental Therapeutics
- Publisher
- Elsevier BV
- Published
- 1985-07
- Volume
- 234
- Issue
- 1
- Pages
- 120-133
- ISSN
- 0022-3565 (ISSN-L)
- OpenAlex
- W2148624345
- Cited by
- 83
- References
- 0
- FWCI
- 4.10
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Comparison of triazolam and pentobarbital: performance impairment, subjective effects and abuse liability. https://app.cochat.ai/papers/10.1016/s0022-3565(25)23294-3
- The paper
- Roache, J. D., & Griffiths, R. R. (1985). Comparison of triazolam and pentobarbital: performance impairment, subjective effects and abuse liability. The Journal of Pharmacology and Experimental Therapeutics. https://doi.org/10.1016/s0022-3565(25)23294-3
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.